By expenditures
| Name | Title | Type |
|---|---|---|
| Andrea Davis | Executive Director | Auditee |
| Christopher J. Petesch | Principal | Auditee |
| Cami Demaree | Principal, Non-Profits And Employee Benefits Plans | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 369997 | 2024 | 2025-09-30 | Comer Nowling and Associates PC | $13.64M |
| 323078 | 2023 | 2024-09-30 | Comer Nowling & Associates PC | $11.94M |
| 40199 | 2022 | 2023-09-14 | Dauby O'Connor & Zaleski LLC | $9.74M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 369997 | 2024 | 2025-09-30 | 1158045 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158044 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158043 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158042 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158041 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158040 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158039 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158038 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158037 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158036 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158035 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158034 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158033 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158032 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158031 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158030 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158029 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158028 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158027 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158026 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158025 | 2024-004 | Material Weakness | Yes | C |
| 369997 | 2024 | 2025-09-30 | 1158024 | 2024-004 | Material Weakness | Yes | C |
| 323078 | 2023 | 2024-09-30 | 1076756 | 2023-004 | Significant Deficiency | - | P |
| 323078 | 2023 | 2024-09-30 | 1076755 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076754 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076753 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076752 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076751 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076750 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076749 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076748 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076747 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076746 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076745 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076744 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076743 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 1076742 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500314 | 2023-004 | Significant Deficiency | - | P |
| 323078 | 2023 | 2024-09-30 | 500313 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500312 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500311 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500310 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500309 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500308 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500307 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500306 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500305 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500304 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500303 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500302 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500301 | 2023-003 | Significant Deficiency | - | C |
| 323078 | 2023 | 2024-09-30 | 500300 | 2023-003 | Significant Deficiency | - | C |